During the past decade, Louisiana State University School of Medicine conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisiana State University School of Medicine" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials, followed by "Abbott" with 3 trials sponsored, "Vanderbilt University Medical Center" with 3 trials sponsored, "Novartis Pharmaceuticals" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana State University School of Medicine" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Glaxo Wellcome" with 1 trials as a collaborator, "ICOS Corporation" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana State University School of Medicine" are "HIV Infections" (15 trials), "AIDS Dementia Complex" (3 trials), "Crohn's Disease" (3 trials), "Acute Respiratory Failure" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Louisiana State University School of Medicine" in a lesser frequency.

Most popular intervention types in "Louisiana State University School of Medicine" are "Drug" (31 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (9 trials), "Didanosine" (4 trials), "Amphotericin B" (2 trials), "FOLFOX regimen" (2 trials) and "Fluconazole" (2 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana State University School of Medicine" are 34 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Louisiana State University School of Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Louisiana State University School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana State University School of Medicine, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".